Filing Analysis
TrueBlue, Inc. filed an 8-K to announce its second quarter 2026 financial results and provided updated outlook information for the third quarter and full fiscal year 2026.
📋 Key Facts
- Reporting period: Second quarter ended June 28, 2026.
- Release date of financial results: August 4, 2026.
- Included exhibits: Press Release (99.1), Earnings Results Presentation (99.2), and Investor Roadshow Presentation (99.3).
- Management conference call scheduled for August 4, 2026, at 2:00 p.m. PT.
TrueBlue, Inc. reported the results of its annual shareholder meeting held on May 11, 2026, where all director nominees were elected and executive compensation was approved.
📋 Key Facts
- Annual meeting held on May 11, 2026, with 27,069,137 shares represented.
- Nine directors were elected to serve until the 2027 Annual Meeting.
- Shareholders approved the amendment and restatement of the 2016 Omnibus Incentive Plan.
- Deloitte & Touche LLP was ratified as the independent auditor for the fiscal year ending December 27, 2026.
- The advisory vote on executive compensation passed with 18,365,258 'For' votes and 6,501,307 'Against' votes.
TrueBlue, Inc. entered into an amendment to its Rights Agreement to accelerate the expiration of its shareholder rights plan (poison pill). The expiration date was moved from May 13, 2026, to May 6, 2026, effectively terminating the plan immediately.
📋 Key Facts
- The First Amendment to the Rights Agreement was signed on May 6, 2026, with Computershare Trust Company, N.A.
- The amendment changed the final expiration date of the Rights from May 13, 2026, to May 6, 2026.
- The original Rights Agreement was established on May 14, 2025.
- The filing includes Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.03 (Material Modification to Rights of Security Holders).
TrueBlue, Inc. reported its first quarter 2026 financial results for the period ended March 29, 2026, and provided guidance for the second quarter and full fiscal year 2026. The filing includes supplemental materials such as an earnings slide presentation and an updated investor roadshow presentation.
📋 Key Facts
- Reported Q1 2026 financial results for the period ended March 29, 2026.
- Provided financial outlook for Q2 2026 and the full fiscal year 2026.
- Management hosted a conference call on May 5, 2026, at 2:00 p.m. PT to discuss results.
- Included Exhibit 99.3, an Investor Roadshow Presentation, for use in future investor conferences.
- The report was signed by Carl R. Schweihs, Chief Financial Officer and Executive Vice President.
TrueBlue, Inc. entered into a cooperation agreement with activist investor EHS Azure Opportunity Fund LP and Eric H. Su to appoint a new independent director to the Board. The agreement avoids a proxy contest for the 2026 Annual Meeting and includes customary standstill and voting commitments.
🚩 Red Flags
- Presence of an activist investor (EHS) suggesting dissatisfaction with current management or performance.
- Requirement for a 'mutually agreed' director indicates the board is yielding to outside pressure.
📋 Key Facts
- Agreement entered on April 10, 2026, with Eric H. Su and EHS Azure Opportunity Fund LP.
- TrueBlue will appoint a mutually agreed-upon independent director no later than September 30, 2026.
- EHS has agreed to support the Company’s slate of director nominees for the 2026 Annual Meeting.
- EHS must maintain a Net Long Position of at least 1.0% of outstanding shares to retain replacement director rights.
- The agreement includes customary standstill, non-disparagement, and expense reimbursement provisions.
TrueBlue, Inc. filed an 8-K to announce its fourth quarter and fiscal year 2025 financial results and provided guidance for the upcoming first quarter and full fiscal year 2026.
📋 Key Facts
- Reporting period: Fourth quarter ended December 28, 2025.
- Earnings call scheduled for February 18, 2026, at 2:00 p.m. PT.
- The filing includes a press release (Exhibit 99.1), earnings presentation (Exhibit 99.2), and an Investor Roadshow Presentation (Exhibit 99.3).
- Management provided outlook information for Q1 and FY 2026.
TrueBlue, Inc. has entered into a Second Amendment to its Credit Agreement, transitioning from a cash-flow based revolving credit facility to an asset-based lending (ABL) facility. This amendment significantly reduces the company's immediate line of credit from $255 million to $175 million.
🚩 Red Flags
- Significant reduction in liquidity/credit availability (from $255M to $175M).
- Shift to Asset-Based Lending (ABL) often indicates lenders are tightening terms due to increased perceived risk or deteriorating cash flow metrics.
- Introduction of a 'springing' fixed charge coverage ratio covenant, which could trigger restrictive financial testing if liquidity/excess availability drops.
📋 Key Facts
- Effective Date: January 30, 2026.
- Transition from cash-flow based revolving credit to an asset-based lending (ABL) facility.
- Credit line reduction: From $255 million down to $175 million (subject to borrowing base calculations).
- Borrowing base components: 90% of Investment Grade Eligible Accounts, 85% of Non-Investment Grade Eligible Accounts, and 80% of Eligible Unbilled Accounts.
- Includes a minimum excess availability covenant, which may convert to a springing fixed charge coverage ratio covenant after September 27, 2026, if certain thresholds are met.
- The company retains an option to increase the amount by $150 million subject to lender approval.
TrueBlue, Inc. announced the appointment of Brian Capone as Senior Vice President and Chief Accounting Officer, effective January 12, 2026. He succeeds Carl Schweihs in the principal accounting officer role, though Mr. Schweihs will remain with the company as CFO.
📋 Key Facts
- Brian Capone appointed SVP and Chief Accounting Officer effective Jan 12, 2026.
- Capone succeeds Carl Schweihs as principal accounting officer; Schweihs remains EVP and CFO.
- Capone's base salary is $315,000 per annum.
- One-time cash award of 40% of base salary, vesting ratably over four years.
- Potential equity awards up to 30% of base salary starting in 2027.
- Capone previously held leadership roles at Avaya, embecta Corp., Cantel Medical, Stryker, and Quest Diagnostics.
TrueBlue, Inc. issued a press release in response to a proxy contest initiated by EHS Management, LLC, which intends to nominate director candidates at the 2026 annual meeting.
🚩 Red Flags
- Proxy contest/activist investor intervention (EHS Management, LLC) often indicates shareholder dissatisfaction with current management or board direction.
📋 Key Facts
- EHS Management, LLC has disclosed intent to nominate director candidates for the 2026 annual meeting of shareholders.
- The Company issued a press release on January 8, 2026, responding to this nomination intent.
- The company's response focuses on recent board refreshment and strategic initiatives aimed at long-term profitable growth.
TrueBlue, Inc. announced the departure of Kristy Willis, Executive Vice President, PeopleReady, effective December 10, 2025. The company stated the departure was not due to any disagreement regarding operations, policies, or practices.
📋 Key Facts
- Kristy Willis departed from her role as Executive Vice President, PeopleReady on December 10, 2025.
- The departure is characterized by the company as not being related to any disagreements with management or company practices.
TrueBlue, Inc. announced the appointment of two new members to its Board of Directors, William Greenblatt and William Seward, effective January 5, 2026. The appointments follow an extensive search process involving shareholder input.
📋 Key Facts
- William Greenblatt appointed to the Board; founder of Montague Street Capital and former CEO/Co-CEO of Sterling Check Corporation.
- William Seward appointed to the Board; currently EVP and COO of Vestis Corporation, formerly President of UPS Supply Chain Solutions.
- Appointments are effective January 5, 2026.
- The Board expects to return to a size of nine directors at the 2026 Annual Meeting of Shareholders.
- New directors will receive compensation consistent with other non-employee directors.
TrueBlue, Inc. filed an 8-K to announce its third quarter financial results for the period ended September 28, 2025, and provided updated guidance for the fourth quarter and full fiscal year 2025.
📋 Key Facts
- Reporting of Q3 2025 financial results (period ended Sept 28, 2025).
- Issuance of outlook/guidance for Q4 2025 and full fiscal year 2025.
- Management conference call scheduled for November 3, 2025, at 2:00 p.m. PT.
- Release of an Investor Roadshow Presentation (Exhibit 99.3).
TrueBlue, Inc. filed an 8-K to announce its second quarter 2025 financial results and provided updated outlook information for the third quarter and full fiscal year 2025.
📋 Key Facts
- Reporting period: Second quarter ended June 29, 2025.
- Earnings call scheduled for August 4, 2025, at 2:00 p.m. PT / 5:00 p.m. ET.
- Included an Investor Roadshow Presentation (Exhibit 99.3) for future investor conferences.
- Provided financial outlook updates for Q3 and FY 2025.
TrueBlue, Inc. reported the results of its annual meeting of shareholders held on May 14, 2025. Shareholders voted to elect nine directors, approve executive compensation on an advisory basis, amend the 2016 Omnibus Incentive Plan, and ratify Deloitte & Touche LLP as independent auditors.
📋 Key Facts
- Annual meeting held on May 14, 2025.
- Total shares present (in person or by proxy): 27,085,588.
- All nine director nominees were elected to serve until the 2025 Annual Meeting of Shareholders.
- The advisory vote on executive compensation received significant support with 21,414,998 votes 'For'.
- Shareholders approved the amendment and restatement of the 2016 Omnibus Incentive Plan (22,836,101 'For').
- Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 28, 2025.
TrueBlue, Inc. has implemented a 'poison pill' shareholder rights plan in response to an unsolicited acquisition proposal from HireQuest, Inc. at $7.50 per share. The plan is designed to prevent coercive or undervalued takeover attempts by allowing existing shareholders to purchase preferred stock at a significant discount if an acquiring person reaches certain ownership thresholds.
🚩 Red Flags
- Hostile takeover environment: The company is actively defending against an unsolicited $7.50/share bid.
- Significant potential dilution: The 'poison pill' mechanism is designed to heavily dilute any entity attempting a rapid accumulation of shares.
- Complexity and litigation risk: Implementation of shareholder rights plans often leads to legal challenges from activist investors or acquirers.
📋 Key Facts
- Unsolicited bid received from HireQuest, Inc. to acquire all common stock at $7.50 per share.
- Board declared a dividend of one preferred stock purchase right (a 'Right') for each share of Common Stock outstanding on May 28, 2025.
- Rights allow holders to purchase 1/100th of a share of Series A Preferred Stock at $30 per 1/100th share ($3,000 per full share equivalent) upon a trigger event.
- Triggering events include an 'Acquiring Person' reaching 15% ownership (or 20% for passive institutional investors).
- The plan includes a 'flip-in' provision: if an acquiring person triggers the rights, other shareholders can purchase common stock at a 50% discount (two times the current purchase price).
- Rights expire on May 13, 2026, unless extended or approved by stockholders.
TrueBlue, Inc. announced that its Board of Directors unanimously rejected an unsolicited, non-binding all-stock acquisition proposal from HireQuest, Inc. The bid offered $7.50 per share for all common shares.
🚩 Red Flags
- Unsolicited bids can sometimes indicate market volatility or a perceived undervaluation by the company.
📋 Key Facts
- Unsolicited, non-binding proposal received from HireQuest, Inc.
- Proposal was for an all-stock transaction to acquire all common shares of TrueBlue.
- Offer price was $7.50 per share.
- The Board of Directors unanimously rejected the bid on May 13, 2025.
TrueBlue, Inc. filed an 8-K to announce its first quarter financial results for the period ended March 30, 2025, and provided updated guidance for the second quarter and full fiscal year 2025.
📋 Key Facts
- Reporting of Q1 2025 financial results (ended March 30, 2025).
- Issuance of outlook information for Q2 2025 and Fiscal Year 2025.
- Management conference call scheduled for May 5, 2025, at 2:00 p.m. PT.
- Release of an Investor Roadshow Presentation (Exhibit 99.3).
TrueBlue, Inc. filed an 8-K to announce its fourth quarter and fiscal year 2024 financial results and provided guidance for the first quarter and full fiscal year 2025.
📋 Key Facts
- Reporting period: Fourth quarter ended December 29, 2024.
- Financial results and outlook for Q1 and FY 2025 were released on February 19, 2025.
- Management held a conference call to discuss earnings on February 19, 2025.
- Included an Investor Roadshow Presentation as part of the disclosure.
TrueBlue, Inc. announced the acquisition of Healthcare Staffing Professionals, Inc. (HSP), a staffing solutions provider specializing in healthcare and government-sector roles.
📋 Key Facts
- Acquisition date: Announced February 4, 2025
- Target company: Healthcare Staffing Professionals, Inc. (HSP)
- HSP focus areas: Nursing, allied health, behavioral health, research, IT, and administrative roles.
- HSP client base: State and local government entities, public health departments, correctional institutions, and education systems.
TrueBlue, Inc. filed an 8-K to announce its third quarter 2024 financial results and provided updated outlook information for the fourth quarter and full fiscal year 2024.
📋 Key Facts
- Reporting period: Third quarter ended September 29, 2024.
- Included an earnings press release (Exhibit 99.1) and a slide presentation (Exhibit 99.2).
- Provided an Investor Roadshow Presentation (Exhibit 99.3).
- Management scheduled a conference call for November 4, 2024, at 2:00 p.m. PT.
TrueBlue, Inc. announced a leadership transition within its finance department involving the promotion of Jason Embick to Chief Accounting Officer and the reassignment of Richard Christensen to Senior Vice President - Risk, Treasury, and Corporate Development.
🚩 Red Flags
- None identified; this appears to be a standard internal reorganization and promotion.
📋 Key Facts
- Jason Embick promoted to SVP and Chief Accounting Officer effective August 19, 2024.
- Richard Christensen transitioning from CAO to SVP - Risk, Treasury, and Corporate Development.
- Mr. Embick's new compensation includes a $280,000 base salary plus potential bonuses/RSUs up to 40% of base salary.
- Mr. Embick joined the company in March 2020 as VP, Corporate Controller.
TrueBlue, Inc. filed an 8-K to announce its second quarter 2024 financial results and provided updated outlook information for the third quarter and full fiscal year 2024.
📋 Key Facts
- Reporting of financial results for the second quarter ended June 30, 2024.
- Release of outlook information for Q3 and FY 2024.
- Management conference call scheduled for August 5, 2024, at 2:00 p.m. PT.
- Included an Investor Roadshow Presentation (Exhibit 99.3) for future investor conferences.
TrueBlue, Inc. reported the results of its annual meeting of shareholders held on May 15, 2024. Shareholders approved the election of nine directors, executive compensation (advisory), an amendment to the 2016 Omnibus Incentive Plan, and the ratification of Deloitte & Touche LLP as independent auditors.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- Annual meeting held on May 15, 2024.
- Total shares present at meeting: 28,854,874.
- All nine director nominees were elected to serve until the 2025 Annual Meeting.
- Shareholders approved an advisory vote on named executive officer compensation (Say-on-Pay).
- Shareholders approved the amendment and restatement of the 2016 Omnibus Incentive Plan.
- Deloitte & Touche LLP was ratified as independent registered public accounting firm for fiscal year ending Dec 29, 2024.
TrueBlue, Inc. filed an 8-K to announce its first quarter 2024 financial results and provide updated guidance for the second quarter and full fiscal year 2024.
📋 Key Facts
- Reporting of Q1 2024 financial results (ended March 31, 2024).
- Issuance of outlook information for Q2 2024 and Fiscal Year 2024.
- Release of an Investor Roadshow Presentation (Exhibit 99.3) for future investor conferences.
TrueBlue, Inc. filed an 8-K to announce its fourth quarter 2023 financial results and provided guidance for the first quarter and full fiscal year 2024. The filing includes a press release, earnings presentation, and investor roadshow materials.
📋 Key Facts
- Reporting period: Fourth quarter ended December 31, 2023.
- The company issued a press release (Exhibit 99.1) regarding financial results and outlook for Q1 and FY 2024.
- Management held an earnings conference call on February 21, 2024.
- Included an Investor Roadshow Presentation (Exhibit 99.3) for future investor conferences.
TrueBlue, Inc. entered into an Amended and Restated Credit Agreement on February 9, 2024, which amends their existing credit facility. The agreement provides for a senior secured revolving line of credit of up to $255 million with an accordion feature allowing increases up to $405 million.
🚩 Red Flags
- Variable interest rate structure increases sensitivity to interest rate fluctuations (SOFR/Base Rate).
- Financial covenants (asset coverage and fixed charge coverage) impose operational restrictions and risks of default if financial performance declines.
📋 Key Facts
- Entered into Amended and Restated Credit Agreement on February 9, 2024.
- Provides a senior secured revolving line of credit facility of up to $255 million.
- Includes an 'Accordion' feature allowing the company to increase the total facility amount up to $405 million.
- The agreement matures in five years.
- Contains financial covenants including an asset coverage ratio test (to be replaced by a consolidated leverage ratio test after Dec 28, 2025) and a quarterly fixed charge coverage ratio test.
- Interest rates are variable based on SOFR or the Base Rate plus applicable spreads tied to leverage ratios.